Last reviewed · How we verify
NCT05827809
Feasibility, Acceptability and Effect of a Transdiagnostic Psychological Treatment for Anxiety and Depression in Youth.
NA trial testing Unified Protocol (UP-C/A) for children and youth with anxiety disorders and /or depression in Anxiety Depression in 40 participants. Completed in 30 October 2024.
28 August 2024
Quick facts
| Lead sponsor | Lena Reuterskiold |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 8 August 2022 |
| Primary completion | 28 August 2024 |
| Estimated completion | 30 October 2024 |
| Sites | 2 locations across Sweden |
Drugs / interventions tested
- Unified Protocol (UP-C/A) for children and youth with anxiety disorders and /or depression
Conditions studied
- Anxiety Depression — all drugs for Anxiety Depression →
- CBT — all drugs for CBT →
Sponsor
Lena Reuterskiold
Who can join
Adults 7 to 17, any sex, with Anxiety Depression or CBT. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this open clinical trial is to try out and evaluate a relatively new transdiagnostic psychological treatment, Unified Protocol (UP-C/A), in group format for children and adolescents aged 7-17 years of age with anxiety and/or depression and their parents, in primary care. The therapists in the project will receive training and on-going supervision in UP-C/A. The main questions it aims to answer are: 1. What are the children's (patients) and parents experience of undergoing a transdiagnostic psychological treatment (UP-C/A) in primary care? 2. What are the therapists' experience of having carried out the treatment with a transdiagnostic psychological treatment (UP-C/A) in primary care? 3. To what extent do children and parents answer self-reports and clinician administered instruments regarding symptoms of anxiety, depression, function and quality of life? 4. To what extent do children and their parents complete the treatment and what is the dropout rate? 5. What does the distribution of diagnoses and co-morbidity look like for patients included in the study? 6. What is the treatment outcome with regard to emotion regulation, symptoms of anxiety, depression, function and quality of life? rated by patients, parents and therapists. 7. To what extent are any effects maintained at a 6-month follow-up? The participants and their parents will partake in group treatment with Unified Protocol of 11 sessions following an initial screening with the Mini International Neuropsychiatric Interview for children and adolescents (MINI-KID).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05827809
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Anxiety Depression
Currently open trials in the same condition.
- NCT07136584 — SOS for Caregiver Wellbeing · NA · recruiting
- NCT07151573 — Evaluating the Big Five Intervention in Norway · NA · recruiting
- NCT07089914 — Health Surveillance at University of Applied Science Hamburg (HAW) · active not recruiting
- NCT06770517 — Exposure Therapy for Late-life Anxiety · NA · recruiting
- NCT06441786 — A Metacognitive Group Therapy of Depression and Anxiety in Youth With Autism · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05827809 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Lena Reuterskiold
- Last refreshed: 24 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05827809.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing